US Stock MarketDetailed Quotes

ABT Abbott Laboratories

Watchlist
  • 114.990
  • -0.280-0.24%
Close Dec 27 16:00 ET
  • 114.400
  • -0.590-0.51%
Post 20:01 ET
199.45BMarket Cap34.95P/E (TTM)

Abbott Laboratories Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
44.11%2.71B
62.93%1.96B
-10.32%1.03B
-24.21%7.26B
30.61%3.04B
-32.48%1.88B
-50.08%1.2B
-44.65%1.14B
-9.04%9.58B
-24.16%2.33B
Net income from continuing operations
14.62%1.65B
-5.31%1.3B
-7.06%1.23B
-17.45%5.72B
54.31%1.59B
0.07%1.44B
-31.86%1.38B
-46.14%1.32B
-1.95%6.93B
-48.06%1.03B
Operating gains losses
----
----
----
-41.40%126M
----
----
----
----
290.91%215M
----
Depreciation and amortization
-2.79%801M
0.63%805M
-0.12%805M
-0.73%3.24B
0.74%813M
1.10%824M
-2.68%800M
-2.07%806M
-7.66%3.27B
-8.61%807M
Other non cash items
87.71%-22M
121.21%140M
30.48%-748M
----
----
-352.11%-179M
-817.39%-660M
-424.88%-1.08B
----
----
Change In working capital
150.78%163M
3.60%-428M
-201.61%-561M
-62.94%-2.48B
-1,436.84%-1.52B
-195.54%-321M
33.13%-444M
85.75%-186M
-97.02%-1.52B
207.55%114M
-Change in receivables
87.64%-57M
-65.82%-325M
-164.81%-151M
-423.53%-356M
-80.06%68M
-186.98%-461M
-4.26%-196M
131.03%233M
82.25%-68M
280.42%341M
-Change in inventory
57.14%220M
58.47%-103M
2.15%-410M
83.58%-232M
256.08%295M
172.16%140M
47.90%-248M
24.37%-419M
-209.87%-1.41B
-1,360.00%-189M
-Change in prepaid assets
----
----
----
-622.67%-542M
----
----
----
----
75.96%-75M
----
-Change in payables and accrued expense
----
----
----
-280.95%-760M
----
----
----
----
-67.39%420M
----
-Change in other working capital
----
----
----
-52.74%-585M
----
----
----
----
57.82%-383M
----
Cash from discontinued investing activities
Operating cash flow
44.11%2.71B
62.93%1.96B
-10.32%1.03B
-24.21%7.26B
30.61%3.04B
-32.48%1.88B
-50.08%1.2B
-44.65%1.14B
-9.04%9.58B
-24.16%2.33B
Investing cash flow
Cash flow from continuing investing activities
6.31%-594M
62.65%-453M
8.01%-425M
-80.06%-3.13B
-30.38%-824M
-30.99%-634M
-359.47%-1.21B
-28.33%-462M
13.35%-1.74B
5.81%-632M
Net PPE purchase and sale
0.71%-556M
-5.13%-533M
-4.74%-398M
-23.92%-2.2B
-23.77%-755M
-19.91%-560M
-33.77%-507M
-18.38%-380M
5.73%-1.78B
0.65%-610M
Net business purchase and sale
--0
----
----
-1,843.75%-837M
--0
---51M
----
----
190.57%48M
--0
Net investment purchase and sale
-5.26%-40M
-2.53%77M
67.44%-28M
-251.52%-116M
-136.67%-71M
-80.95%-38M
33.90%79M
-109.76%-86M
65.63%-33M
56.52%-30M
Net other investing changes
-86.67%2M
100.00%2M
-75.00%1M
0.00%22M
-75.00%2M
275.00%15M
-87.50%1M
100.00%4M
-15.38%22M
-33.33%8M
Cash from discontinued investing activities
Investing cash flow
6.31%-594M
62.65%-453M
8.01%-425M
-80.06%-3.13B
-30.38%-824M
-30.99%-634M
-359.47%-1.21B
-28.33%-462M
13.35%-1.74B
5.81%-632M
Financing cash flow
Cash flow from continuing financing activities
32.65%-1.58B
38.63%-791M
16.60%-1.18B
7.14%-7.09B
-40.84%-2.05B
-51.65%-2.34B
-58.55%-1.29B
63.12%-1.41B
-38.99%-7.64B
22.75%-1.46B
Net issuance payments of debt
102.86%43M
1,233.33%160M
-202.38%-127M
-254.08%-2.48B
-9,490.00%-939M
-6,375.00%-1.51B
20.00%12M
94.35%-42M
-181.85%-699M
105.10%10M
Net common stock issuance
-37,450.00%-751M
99.30%-3M
58.15%-226M
67.67%-1.23B
62.19%-259M
99.75%-2M
-8,420.00%-426M
76.59%-540M
-65.07%-3.8B
29.67%-685M
Cash dividends paid
-8.11%-960M
-7.98%-961M
-7.53%-957M
-7.46%-3.56B
-7.90%-888M
-7.51%-888M
-7.49%-890M
-6.97%-890M
-3.34%-3.31B
-3.13%-823M
Proceeds from stock option exercised by employees
64.29%92M
-13.33%13M
116.13%134M
0.00%167M
-17.07%34M
-1.75%56M
50.00%15M
5.08%62M
-34.51%167M
-50.00%41M
Cash from discontinued financing activities
Financing cash flow
32.65%-1.58B
38.63%-791M
16.60%-1.18B
7.14%-7.09B
-40.84%-2.05B
-51.65%-2.34B
-58.55%-1.29B
63.12%-1.41B
-38.99%-7.64B
22.75%-1.46B
Net cash flow
Beginning cash position
-10.82%6.99B
-31.40%6.28B
-30.22%6.9B
0.85%9.88B
-30.07%6.71B
-12.33%7.84B
19.36%9.16B
0.85%9.88B
43.30%9.8B
3.14%9.59B
Current changes in cash
148.77%535M
155.12%716M
20.99%-576M
-1,545.37%-2.96B
-31.65%162M
-245.68%-1.1B
-197.45%-1.3B
65.58%-729M
-93.24%205M
-53.53%237M
Effect of exchange rate changes
224.14%36M
51.85%-13M
-550.00%-36M
81.15%-23M
-50.98%25M
69.79%-29M
61.97%-27M
233.33%8M
-74.29%-122M
492.31%51M
End cash Position
12.65%7.56B
-10.82%6.99B
-31.40%6.28B
-30.22%6.9B
-30.22%6.9B
-30.07%6.71B
-12.33%7.84B
19.36%9.16B
0.85%9.88B
0.85%9.88B
Free cash flow
63.17%2.15B
105.03%1.43B
-17.82%627M
-35.17%5.06B
33.04%2.28B
-43.06%1.32B
-65.73%696M
-56.25%763M
-9.76%7.8B
-30.04%1.72B
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 44.11%2.71B62.93%1.96B-10.32%1.03B-24.21%7.26B30.61%3.04B-32.48%1.88B-50.08%1.2B-44.65%1.14B-9.04%9.58B-24.16%2.33B
Net income from continuing operations 14.62%1.65B-5.31%1.3B-7.06%1.23B-17.45%5.72B54.31%1.59B0.07%1.44B-31.86%1.38B-46.14%1.32B-1.95%6.93B-48.06%1.03B
Operating gains losses -------------41.40%126M----------------290.91%215M----
Depreciation and amortization -2.79%801M0.63%805M-0.12%805M-0.73%3.24B0.74%813M1.10%824M-2.68%800M-2.07%806M-7.66%3.27B-8.61%807M
Other non cash items 87.71%-22M121.21%140M30.48%-748M---------352.11%-179M-817.39%-660M-424.88%-1.08B--------
Change In working capital 150.78%163M3.60%-428M-201.61%-561M-62.94%-2.48B-1,436.84%-1.52B-195.54%-321M33.13%-444M85.75%-186M-97.02%-1.52B207.55%114M
-Change in receivables 87.64%-57M-65.82%-325M-164.81%-151M-423.53%-356M-80.06%68M-186.98%-461M-4.26%-196M131.03%233M82.25%-68M280.42%341M
-Change in inventory 57.14%220M58.47%-103M2.15%-410M83.58%-232M256.08%295M172.16%140M47.90%-248M24.37%-419M-209.87%-1.41B-1,360.00%-189M
-Change in prepaid assets -------------622.67%-542M----------------75.96%-75M----
-Change in payables and accrued expense -------------280.95%-760M-----------------67.39%420M----
-Change in other working capital -------------52.74%-585M----------------57.82%-383M----
Cash from discontinued investing activities
Operating cash flow 44.11%2.71B62.93%1.96B-10.32%1.03B-24.21%7.26B30.61%3.04B-32.48%1.88B-50.08%1.2B-44.65%1.14B-9.04%9.58B-24.16%2.33B
Investing cash flow
Cash flow from continuing investing activities 6.31%-594M62.65%-453M8.01%-425M-80.06%-3.13B-30.38%-824M-30.99%-634M-359.47%-1.21B-28.33%-462M13.35%-1.74B5.81%-632M
Net PPE purchase and sale 0.71%-556M-5.13%-533M-4.74%-398M-23.92%-2.2B-23.77%-755M-19.91%-560M-33.77%-507M-18.38%-380M5.73%-1.78B0.65%-610M
Net business purchase and sale --0---------1,843.75%-837M--0---51M--------190.57%48M--0
Net investment purchase and sale -5.26%-40M-2.53%77M67.44%-28M-251.52%-116M-136.67%-71M-80.95%-38M33.90%79M-109.76%-86M65.63%-33M56.52%-30M
Net other investing changes -86.67%2M100.00%2M-75.00%1M0.00%22M-75.00%2M275.00%15M-87.50%1M100.00%4M-15.38%22M-33.33%8M
Cash from discontinued investing activities
Investing cash flow 6.31%-594M62.65%-453M8.01%-425M-80.06%-3.13B-30.38%-824M-30.99%-634M-359.47%-1.21B-28.33%-462M13.35%-1.74B5.81%-632M
Financing cash flow
Cash flow from continuing financing activities 32.65%-1.58B38.63%-791M16.60%-1.18B7.14%-7.09B-40.84%-2.05B-51.65%-2.34B-58.55%-1.29B63.12%-1.41B-38.99%-7.64B22.75%-1.46B
Net issuance payments of debt 102.86%43M1,233.33%160M-202.38%-127M-254.08%-2.48B-9,490.00%-939M-6,375.00%-1.51B20.00%12M94.35%-42M-181.85%-699M105.10%10M
Net common stock issuance -37,450.00%-751M99.30%-3M58.15%-226M67.67%-1.23B62.19%-259M99.75%-2M-8,420.00%-426M76.59%-540M-65.07%-3.8B29.67%-685M
Cash dividends paid -8.11%-960M-7.98%-961M-7.53%-957M-7.46%-3.56B-7.90%-888M-7.51%-888M-7.49%-890M-6.97%-890M-3.34%-3.31B-3.13%-823M
Proceeds from stock option exercised by employees 64.29%92M-13.33%13M116.13%134M0.00%167M-17.07%34M-1.75%56M50.00%15M5.08%62M-34.51%167M-50.00%41M
Cash from discontinued financing activities
Financing cash flow 32.65%-1.58B38.63%-791M16.60%-1.18B7.14%-7.09B-40.84%-2.05B-51.65%-2.34B-58.55%-1.29B63.12%-1.41B-38.99%-7.64B22.75%-1.46B
Net cash flow
Beginning cash position -10.82%6.99B-31.40%6.28B-30.22%6.9B0.85%9.88B-30.07%6.71B-12.33%7.84B19.36%9.16B0.85%9.88B43.30%9.8B3.14%9.59B
Current changes in cash 148.77%535M155.12%716M20.99%-576M-1,545.37%-2.96B-31.65%162M-245.68%-1.1B-197.45%-1.3B65.58%-729M-93.24%205M-53.53%237M
Effect of exchange rate changes 224.14%36M51.85%-13M-550.00%-36M81.15%-23M-50.98%25M69.79%-29M61.97%-27M233.33%8M-74.29%-122M492.31%51M
End cash Position 12.65%7.56B-10.82%6.99B-31.40%6.28B-30.22%6.9B-30.22%6.9B-30.07%6.71B-12.33%7.84B19.36%9.16B0.85%9.88B0.85%9.88B
Free cash flow 63.17%2.15B105.03%1.43B-17.82%627M-35.17%5.06B33.04%2.28B-43.06%1.32B-65.73%696M-56.25%763M-9.76%7.8B-30.04%1.72B
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.